PVP Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on August 28, 2025.

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

PVP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹20.99

prior close

₹20.37

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-0.1% vs market

Residential Commercial Projects peers, median of 60sector-1.3%+0.5% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.5 pts more than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.5

15m

+0.1

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8-0.7-0.1-1.3+0.5

Next day

-0.2-0.9+0.7-1.9+1.7

+1.1+0.4+0.7-1.5+2.6

+2.4+1.3+1.1+0.1+2.3

+4.1+2.3+1.8+0.8+3.3

+14.3+1.6+12.8+0.4+14.0

+52.2+2.0+50.2-0.4+52.6

15d

+44.0+4.2+39.8+2.1+41.9

+46.5-1.0+47.5-3.1+49.6

+70.4+2.6+67.7-0.2+70.5

+76.7-0.4+77.0-4.0+80.7

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

PVP Ventures Limited's Board has approved acquiring an initial 41.2% stake in 7Med India Pvt. Ltd., a Delhi NCR-based healthcare company specializing in renal care, dialysis, nephrology and urology, with a contracted path to majority ownership within 12 months and a roadmap to increase holding to 76% over time. The total outlay is around INR 127 crores through a combination of primary and secondary share purchases, paid in cash. 7Med operates 22 dialysis centres across 6 states plus 4 super-specialty hospitals, employs 450+ professionals, and is among India's top 5 organized players in renal care. The company currently has an EBITDA of about INR 10 crores and targets INR 50 crores EBITDA in 4 years.

Likely market impact

This marks a significant diversification move by PVP Ventures into the healthcare services sector, using cash flows from its legacy real estate assets. The acquisition adds a profitable, scalable healthcare platform to PVP's portfolio, potentially creating long-term value for shareholders if 7Med achieves its growth targets.